基于核因子-κB活性评估，使用蛋白酶体抑制剂硼替佐米成功治疗T细胞急性淋巴细胞白血病。 - Suppr

Suppr

超能文献

Successful T-cell acute lymphoblastic leukemia treatment with proteasome inhibitor bortezomib based on evaluation of nuclear factor-κB activity.

作者信息

Hu Xiaohui, Xu Jingjing, Sun Aining, Shen Yaying, He Guangsheng, Guo Feng

出版信息

Leuk Lymphoma. 2011 Dec;52(12):2393-5. doi: 10.3109/10428194.2011.593271. Epub 2011 Jul 12.

DOI:10.3109/10428194.2011.593271

PMID:21745166

Abstract

摘要

相似文献

Successful T-cell acute lymphoblastic leukemia treatment with proteasome inhibitor bortezomib based on evaluation of nuclear factor-κB activity.基于核因子-κB活性评估，使用蛋白酶体抑制剂硼替佐米成功治疗T细胞急性淋巴细胞白血病。

Leuk Lymphoma. 2011 Dec;52(12):2393-5. doi: 10.3109/10428194.2011.593271. Epub 2011 Jul 12.

Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma.在复发性头颈部鳞状细胞癌患者中，蛋白酶体抑制剂硼替佐米与再照射联合治疗期间对核因子-κB及其靶基因的抑制作用

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1400-12. doi: 10.1016/j.ijrobp.2005.05.007. Epub 2005 Jul 11.

Cancer research. Taking garbage in, tossing cancer out?癌症研究。输入垃圾，排出癌症？

Science. 2002 Jan 25;295(5555):612-3. doi: 10.1126/science.295.5555.612.

Differential ex vivo activity of bortezomib in newly diagnosed paediatric acute lymphoblastic and myeloblastic leukaemia.硼替佐米在新诊断的小儿急性淋巴细胞性和髓性白血病中的体外差异活性。

Anticancer Res. 2010 Jun;30(6):2119-24.

Drug interactions between the proteasome inhibitor bortezomib and cytotoxic chemotherapy, tumor necrosis factor (TNF) alpha, and TNF-related apoptosis-inducing ligand in prostate cancer.蛋白酶体抑制剂硼替佐米与细胞毒性化疗、肿瘤坏死因子（TNF）α以及前列腺癌中TNF相关凋亡诱导配体之间的药物相互作用。

Clin Cancer Res. 2003 Oct 1;9(12):4537-45.

The proteasome--an emerging therapeutic target in cancer.蛋白酶体——癌症中一个新兴的治疗靶点。

N Engl J Med. 2003 Jun 26;348(26):2597-8. doi: 10.1056/NEJMp030092.

A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study.蛋白酶体抑制剂硼替佐米用于难治性白血病患儿的1期研究：一项儿童肿瘤研究组的研究。

Clin Cancer Res. 2007 Mar 1;13(5):1516-22. doi: 10.1158/1078-0432.CCR-06-2173.

[Proteasome inhibitor bortezomib as an anticancer drug].[蛋白酶体抑制剂硼替佐米作为一种抗癌药物]

Tanpakushitsu Kakusan Koso. 2006 Aug;51(10 Suppl):1251-6.

Anti-tumor activity of the proteasome inhibitor bortezomib in gastric cancer.硼替佐米蛋白酶体抑制剂对胃癌的抗肿瘤活性。

Int J Oncol. 2011 Dec;39(6):1529-36. doi: 10.3892/ijo.2011.1141. Epub 2011 Jul 22.

The role of bortezomib in the treatment of lymphoma.硼替佐米在淋巴瘤治疗中的作用。

Cancer Invest. 2007 Dec;25(8):766-75. doi: 10.1080/07357900701579570.

引用本文的文献

Therapeutic approaches for HTLV-1-associated adult T-cell leukemia/lymphoma: a comprehensive review.治疗 HTLV-1 相关成人 T 细胞白血病/淋巴瘤的方法：全面综述。

Med Oncol. 2023 Sep 9;40(10):295. doi: 10.1007/s12032-023-02166-8.

The Role of Proteasome Inhibitors in Treating Acute Lymphoblastic Leukaemia.蛋白酶体抑制剂在治疗急性淋巴细胞白血病中的作用

Front Oncol. 2021 Dec 23;11:802832. doi: 10.3389/fonc.2021.802832. eCollection 2021.

Treatment of Acute Lymphoid Leukemia Refractory to Classic First-Line and Rescue Protocols.经典一线及挽救方案难治的急性淋巴细胞白血病的治疗

Int J Hematol Oncol Stem Cell Res. 2020 Apr 1;14(2):123-126.

Bortezomib-containing therapy in Japanese children with relapsed acute lymphoblastic leukemia.硼替佐米联合化疗治疗日本儿童复发急性淋巴细胞白血病

Int J Hematol. 2019 Nov;110(5):627-634. doi: 10.1007/s12185-019-02714-x. Epub 2019 Aug 10.

[Bortezomib and obatoclax for dual blockade of protein degradation pathways show synergistic anti-tumor effect in human acute T lymphoblastic leukemia cells].硼替佐米与 obatoclax 对蛋白质降解途径的双重阻断在人急性 T 淋巴细胞白血病细胞中显示出协同抗肿瘤作用

Nan Fang Yi Ke Da Xue Xue Bao. 2019 Apr 30;39(4):401-408. doi: 10.12122/j.issn.1673-4254.2019.04.04.

Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomib-based chemotherapy.基于硼替佐米的化疗方案治疗难治性/复发性成人急性淋巴细胞白血病

Int J Gen Med. 2015 Jun 12;8:211-4. doi: 10.2147/IJGM.S59537. eCollection 2015.

Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B.核糖体蛋白 L22 的失活通过诱导干性因子 Lin28B 促进转化。

Blood. 2012 Nov 1;120(18):3764-73. doi: 10.1182/blood-2012-03-415349. Epub 2012 Sep 13.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验